T. Zeng

发表

Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells

Hua Jiang, J. Hou, Xue-guang Zhang, 2014, Molecular oncology.

Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1

Fan Zhou, Hua Jiang, J. Hou, 2013, Clinical and Experimental Medicine.

PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature

Weiping Zhou, T. Zeng, Yong Li, 2021, Frontiers in Immunology.

Prednisolone and chlormethine inhibit multiple myeloma through inhibition of Notch / NF-κB-mediated angiogenesis

T. Zeng, Zhen-gang Yuan, C. Tao, 2018 .

Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial

Yong Gao, Yandong Li, Yanan Hai, 2020, Journal of Cancer Research and Clinical Oncology.

Immune‐related lncRNA signature delineates an immune‐excluded subtype of liver cancer with unfavorable clinical outcomes

Lihui Wei, Debin Sun, T. Zeng, 2022, Journal of clinical laboratory analysis.

PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma

Yuan-Yuan Shi, Hong-Yang Wang, Liwei Dong, 2020, Science Translational Medicine.

Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy

Hua Jiang, J. Hou, Li-li Zhou, 2015, Stem Cells International.

LC-MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients.

Shouhong Gao, Wansheng Chen, T. Zeng, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Prognosis of Advanced Cholangiocarcinoma in the Palliative Care Setting: A Series of 201 Cases.

T. Zeng, C. Tao, Zheng-lin Yuan, 2021, Alternative therapies in health and medicine.

Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor

Zheng Yuan, T. Zeng, Zhilei Zheng, 2023, Liver Cancer.

LC-MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients.

Shouhong Gao, Wansheng Chen, T. Zeng, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.